Intergroupe Francophone De Cancerologie Thoracique

This study tests whether adding a new immunotherapy drug (fianlimab) to standard chemo and another immunotherapy (cemiplimab) can control pleural mesothelioma for at least 6 months. It involves 126 adults who have not had prior treatment and whose cancer cannot be removed by surg…

This study looks at the best way to treat advanced non-small cell lung cancer in people who also have interstitial lung disease (ILD), a condition that causes lung scarring. It will test a specific chemotherapy as a first treatment and an immunotherapy drug as a second treatment.…